You might not always take notice, but life is going on all around you. You can take your dog for a walk on a warm summer day and stop to watch a flower open and a flock of birds flies overhead. Everywhere you turn there is evidence of life; some living things are so small that you need a microscope to see them. This is life science. Questions we will try to answer during this seminar: What are the global trends of life science? What are the technologies that are being adopted to advance drug research? Will the digitization of R&D and healthcare increase?
17.30 – Welcome drinks
18.00 – Girls in Tech: Intro
18:15 – 19:00 Round table
19:00 – Q&A moderated
19.25 – Networking drinks
Agnès Simon (Senior Business Director, Patient Monitoring and Diagnostics, EMEA Medtronic)
Agnès holds an MSc in Manufacturing and Biomechanical Engineering from the Swiss Federal Institute of Technology – ETH Zürich. After a career start at The Boston Consulting Group in Zürich, Agnès moved to the MedTech industry in the field of orthopedics. She then joined Medtronic where she has a long history. She commenced working in pelvic health marketing for Europe, she then moved to different regional business leadership roles in Diabetes where she more recently led the EMEA Incentive Insulin Management activities growing the insulin pump and continuous glucose monitoring businesses.
Samareh Azeredo da Silveira Lajaunias, PhD (Managing Director)
Dr. Azeredo da Silveira Lajaunias is specialized in delivering the value of breakthrough biomedical innovations coming from research institutes. In 2007, she founded LASCCO SA, a virtual incubator dedicated to the identification and early-stage development of biomedical discoveries. She built its portfolio, focusing on technologies in the fields of critical care and infectious diseases. From 2011 to 2019, she was a partner at Sepstone Diagnostics, a spin-off of LASCCO, for which she successfully negotiated out-licensing deals with several multinational diagnostic companies. Since 2015, she is Managing Director at Combioxin SA.
Goranka Tanackovic Abbas-Terki (CEO of Gene Predictis)
Goranka Tanackovic Abbas-Terki was trained as a scientist and holds PhD degrees from the University of Zagreb and University of Geneva. In parallel with her PhD studies, she successfully completed an entrepreneurship program at Babson College, Wellesley, USA. During her academic career, she successfully led various research projects, obtained numerous research grants and, results of her work are recognized through the publications in high-impact per-reviewed journals. Since 2011, she is the CEO of Gene Predictis, a pioneering Swiss company specialized in precision medicine offering innovative diagnostic tools based on genetics that allow tailored treatments for patients. Under her direction, the company developed first in class diagnostic products answering important medical needs (e.g. measuring the risk of thrombosis for women using contraceptive pills) and paving the way to a highly personalised medical advice.
Christina Vallgren (CEO of TERAPET)
TERAPET, a CERN start-up, founded by two CERN physicists and a leading oncologist from HUG, develops and commercializes innovative solutions for a safer, more precise and time-saving proton therapy for cancer treatment.
Before coming to CERN, Christina earned an MSc degree in nuclear physics from Chalmers University of Technology, Sweden. Right after her degree in nuclear physics, Christina came to CERN in 2008 for a Ph.D. in applied physics. Since then, she has been working as a physicist at CERN for the last 11 years. She is the main responsible for the LHC (Large Hadron Collider, 27 km, the world’s biggest accelerator) Beam Vacuum (the world’s biggest vacuum system) Operation and has also been a supervisor for five master students and two fellows. From time to time, she is also a scientific journal referee for IEEE Transactions on Nuclear Science.
Alexandra de Toledo (Pharmacist at Pharmacie Principale S.A)
Alexandra de Toledo is a pharmacist and completed an EMBA at the University of Geneva in 2017. Currently, she is responsible for health programs not only for the public as well as employees and managers of companies. The aim of these programs is to prevent chronic diseases (noncommunicable diseases) which are the reason for 75% of mortality in Switzerland and reflects almost 80% of the expenses in the healthcare system. She is also involved in a European research project as part of the Active Assisted Living (AAL) program, which aims to improve the quality of life of people with mild cognitive impairment.
The round table will be moderated by
Lara Rossi (Innovaud)
Lara is the Head of Communications of Innovaud, Vaud’s agency for innovation in Lausanne, Switzerland. She has over 20 years of experience in public relations and communications. Lara has been working for 10 years in the field of science, innovation and startups, for ex. EPFL, venturelab, Venture Kick and now Innovaud
Book your ticket fast!
Please be aware that we will take pictures during the event, which will be published on our Girls in Tech website and social media channels and can be reused for marketing purposes at a later stage.